BERGENBIO And LAVIDE HOLDING On The List Of Winners And Losers Of Monday’s Euronext Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are BERGENBIO, POLIGHT, and AVANTIUM.

Financial Asset Price Change Updated (EST)
BERGENBIO (BGBIO.OL) 11.48 14.76% 2024-10-07 12:24:57
POLIGHT (PLT.OL) 4.68 8.85% 2024-10-07 12:42:22
AVANTIUM (AVTX.AS) 2.23 7.73% 2024-10-07 12:00:38
NORWEGIAN AIR SHUT (NAS.OL) 11.62 6.61% 2024-10-07 12:41:41
GALAPAGOS (GLPG.AS) 27.62 6.23% 2024-10-07 12:02:06
NEL (NEL.OL) 4.84 5.71% 2024-10-07 12:41:25
ALAN ALLMAN (AAA.PA) 5.60 5.66% 2024-10-07 12:45:21
MARTIFER (MAR.LS) 1.85 5.43% 2024-10-07 12:23:29
OXURION (OXUR.BR) 0.37 5% 2024-10-07 12:21:00
BENFICA (SLBEN.LS) 3.46 4.53% 2024-10-07 12:22:57

The three biggest losers today are LAVIDE HOLDING, ATLANTIC SAPPHIRE, and SEQUANA MEDICAL.

Financial Asset Price Change Updated (EST)
LAVIDE HOLDING (LVIDE.AS) 0.36 -14.55% 2024-10-07 12:02:40
ATLANTIC SAPPHIRE (ASA.OL) 0.23 -13.34% 2024-10-07 12:24:41
SEQUANA MEDICAL (SEQUA.BR) 0.70 -8.85% 2024-10-07 12:21:19
HAVILA SHIPPING (HAVI.OL) 3.40 -5.95% 2024-10-07 12:40:24
HYBRID SOFTWARE GR (HYSG.BR) 3.58 -5.79% 2024-10-07 12:20:08
TIETOEVRY (TIETO.OL) 201.00 -5.63% 2024-10-07 12:44:00
SCANA (SCANA.OL) 3.23 -5.56% 2024-10-07 12:42:52
QUESTERRE ENERGY (QEC.OL) 2.26 -5.44% 2024-10-07 12:42:29
TREASURE (TRE.OL) 26.20 -4.41% 2024-10-07 12:44:05
EQUINOR (EQNR.OL) 275.15 -4.21% 2024-10-07 12:25:54

Winners today

1. BERGENBIO (BGBIO.OL)

14.76% Price Change

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat drug resistant, metastatic cancers, and respiratory diseases in Norway. The company's lead clinical asset is the Bemcentinib (BGB016), an inhibitor of AXL receptor tyrosine kinase (AXL), which is in phase 1b/2a clinical trial to treat non-small cell lung cancer; and (BGBC008), which is in phase 2 clinical trial to treat second-line non-small cell lung cancer (2L NSCLC). It develops Bemcentinib, which is in preclinical trial to treat acute respiratory distress syndrome; Tilvestamab (BGB149), anti-AXL monoclonal antibody, which in phase 1 clinical trial for the treatment of ovarian cancer; and Mipasetamab Uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. BerGenBio ASA was incorporated in 2007 and is based in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with BERGENBIO rising 14.76% to €11.48 on Monday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI fell 0.48% to €1,442.48, following the last session’s upward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, BERGENBIO has a trailing twelve months EPS of kr-15.16.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -179.58%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

BERGENBIO’s EBITDA is -2.91.

Moving Average

BERGENBIO’s value is way above its 50-day moving average of kr0.13 and way higher than its 200-day moving average of kr4.18.

More news about BERGENBIO.

2. POLIGHT (PLT.OL)

8.85% Price Change

poLight ASA develops optical lens for consumer devices and industrial applications in Europe, Asia, and the United States. The company's lens replicates the lens of the human eye enabling the implementation of autofocus functions for various applications. Its product portfolio includes TLens, a tuneable optical lens for autofocus camera applications; Packaged TLens that facilitates integration of a TLens on a fixed-focus camera module; driver ASIC is designed to drive capacitive loads such as the TLens autofocus actuators; and evaluation kits that allows to test and evaluate the optical and electrical performance of the TLens in new products and/or applications. It serves smartphones and wearables, industrial, augmented reality, healthcare, and webcams markets. poLight ASA was founded in 2005 and is headquartered in Skoppum, Norway.

Oslo Børs Benchmark Index_GI ended the session with POLIGHT rising 8.85% to €4.68 on Monday while Oslo Børs Benchmark Index_GI dropped 0.48% to €1,442.48.

Earnings Per Share

As for profitability, POLIGHT has a trailing twelve months EPS of kr-1.12.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -35.09%.

Yearly Top and Bottom Value

POLIGHT’s stock is valued at kr4.68 at 22:40 EST, way below its 52-week high of kr25.70 and way higher than its 52-week low of kr2.34.

More news about POLIGHT.

3. AVANTIUM (AVTX.AS)

7.73% Price Change

Avantium N.V., a chemical technology company, develops and commercializes renewable chemistry solutions in the Netherlands. The company operates through three segments: Avantium R&D Solutions, Avantium Renewable Chemistries, and Avantium Renewable Polymers. It offers furandicarboxylic acid, a building block for polyethylene furanoate (PEF); and PEF, a plant-based recyclable plastic for use as packaging material. The company also provides catalyst testing systems, including Flowrence that provides catalyst testing and adsorbents. In addition, it offers R&D system and refinery catalyst testing services. Further, the company develops ray technology to produce mono-ethylene glycol from industrial sugars; and dawn technology which converts non-food plant-based feedstock to industrial sugars and lignin. Additionally, it produces polyesters using plantMEG. The company was founded in 2000 and is headquartered in Amsterdam, the Netherlands.

AEX-Index ended the session with AVANTIUM rising 7.73% to €2.23 on Monday while AEX-Index jumped 0.11% to €912.77.

Earnings Per Share

As for profitability, AVANTIUM has a trailing twelve months EPS of €-0.47.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -36.88%.

More news about AVANTIUM.

4. NORWEGIAN AIR SHUT (NAS.OL)

6.61% Price Change

Norwegian Air Shuttle ASA, together with its subsidiaries, provides air travel services in Norway and internationally. It is also involved in aircraft financing, leasing, and ownership activities; and cargo activities. It operates a fleet of 87 aircrafts. Norwegian Air Shuttle ASA was founded in 1993 and is headquartered in Fornebu, Norway.

Oslo Børs Benchmark Index_GI ended the session with NORWEGIAN AIR SHUT jumping 6.61% to €11.62 on Monday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI slid 0.48% to €1,442.48, following the last session’s upward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, NORWEGIAN AIR SHUT has a trailing twelve months EPS of kr1.59.

PE Ratio

NORWEGIAN AIR SHUT has a trailing twelve months price to earnings ratio of 7.31. Meaning, the purchaser of the share is investing kr7.31 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 37.41%.

More news about NORWEGIAN AIR SHUT.

5. GALAPAGOS (GLPG.AS)

6.23% Price Change

Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.

AEX-Index ended the session with GALAPAGOS jumping 6.23% to €27.62 on Monday, following the last session’s upward trend. AEX-Index jumped 0.11% to €912.77, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, GALAPAGOS has a trailing twelve months EPS of €0.48.

PE Ratio

GALAPAGOS has a trailing twelve months price to earnings ratio of 57.54. Meaning, the purchaser of the share is investing €57.54 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.15%.

Moving Average

GALAPAGOS’s worth is way higher than its 50-day moving average of €25.03 and under its 200-day moving average of €28.46.

Revenue Growth

Year-on-year quarterly revenue growth grew by 29.7%, now sitting on 261.4M for the twelve trailing months.

Volume

Today’s last reported volume for GALAPAGOS is 152481 which is 48.88% above its average volume of 102412.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 362.5% and a negative 148.7%, respectively.

More news about GALAPAGOS.

6. NEL (NEL.OL)

5.71% Price Change

Nel ASA, a hydrogen company, provides various solutions to produce, store, and distribute hydrogen from renewable energy in Norway and internationally. The company operates in two segments, Nel Hydrogen Fueling and Nel Hydrogen Electrolyser. The Nel Hydrogen Fueling segment manufactures hydrogen fueling stations for fuel cell electric vehicles, such as cars, buses, trucks, and other on-road vehicles. The Nel Hydrogen Electrolyser segment supplies hydrogen production equipment based on alkaline and proton exchange membrane water electrolysis technology. It serves industries, energy, and gas companies. The company was formerly known as DiaGenic ASA and changed its name to Nel ASA in October 2014. Nel ASA was founded in 1927 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with NEL rising 5.71% to €4.84 on Monday while Oslo Børs Benchmark Index_GI fell 0.48% to €1,442.48.

Earnings Per Share

As for profitability, NEL has a trailing twelve months EPS of kr-0.35.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.06%.

Sales Growth

NEL’s sales growth for the next quarter is negative 18.7%.

More news about NEL.

7. ALAN ALLMAN (AAA.PA)

5.66% Price Change

Alan Allman Associates, together with its subsidiaries, engages in the provision of consulting services in Canada, France, Belgium, Luxembourg, Switzerland, and Singapore. The company offers technology consulting in the areas, including cybersecurity, cloud, data management, digitalization of tools and processes, etc.; strategy and management consulting comprising risk management, commercial intelligence, market finance, process management, change management, etc.; and industrial transformation consulting, such as purchasing and supply chain issues, relocation, cost reduction, project management, materials, process consulting, etc. The company was incorporated in 1954 and is based in Issy-les-Moulineaux, France.

CAC 40 ended the session with ALAN ALLMAN jumping 5.66% to €5.60 on Monday while CAC 40 rose 0.46% to €7,576.02.

Earnings Per Share

As for profitability, ALAN ALLMAN has a trailing twelve months EPS of €0.13.

PE Ratio

ALAN ALLMAN has a trailing twelve months price to earnings ratio of 43.08. Meaning, the purchaser of the share is investing €43.08 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.5%.

Yearly Top and Bottom Value

ALAN ALLMAN’s stock is valued at €5.60 at 22:40 EST, way under its 52-week low of €8.44.

Volatility

ALAN ALLMAN’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.01%, a negative 1.80%, and a positive 3.77%.

ALAN ALLMAN’s highest amplitude of average volatility was 6.45% (last week), 4.72% (last month), and 3.77% (last quarter).

Volume

Today’s last reported volume for ALAN ALLMAN is 851 which is 30.92% above its average volume of 650.

Moving Average

ALAN ALLMAN’s worth is way below its 50-day moving average of €9.88 and way below its 200-day moving average of €10.73.

More news about ALAN ALLMAN.

8. MARTIFER (MAR.LS)

5.43% Price Change

Martifer SGPS, S.A. operates in the metallic constructions and renewable energy development sectors worldwide. It operates through Metallic Constructions, Naval Industry, and Renewables segments. The Metallic Constructions segment engages in the construction activities involving metal mechanical construction, aluminum, and glass façades, as well as infrastructures for oil and gas. The Naval Industry segment involved in shipbuilding, as well as provides ship repair services. The Renewables segment engages in the development, licensing, building, and operating of renewable energy projects, including wind and solar power projects. The company was founded in 1990 and is headquartered in Oliveira de Frades, Portugal.

PSI ended the session with MARTIFER jumping 5.43% to €1.85 on Monday while PSI jumped 0.69% to €6,693.16.

Earnings Per Share

As for profitability, MARTIFER has a trailing twelve months EPS of €0.2.

PE Ratio

MARTIFER has a trailing twelve months price to earnings ratio of 9.25. Meaning, the purchaser of the share is investing €9.25 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 38.5%.

Volatility

MARTIFER’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.47%, a positive 0.07%, and a positive 1.21%.

MARTIFER’s highest amplitude of average volatility was 0.66% (last week), 1.11% (last month), and 1.21% (last quarter).

Moving Average

MARTIFER’s worth is way above its 50-day moving average of €1.66 and way above its 200-day moving average of €1.64.

Revenue Growth

Year-on-year quarterly revenue growth grew by 9.2%, now sitting on 200.66M for the twelve trailing months.

More news about MARTIFER.

9. OXURION (OXUR.BR)

5% Price Change

Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness. It focuses on developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.

BEL 20 ended the session with OXURION rising 5% to €0.37 on Monday while BEL 20 slid 0.62% to €4,264.18.

Earnings Per Share

As for profitability, OXURION has a trailing twelve months EPS of €97.53.

Yearly Top and Bottom Value

OXURION’s stock is valued at €0.37 at 22:40 EST, way under its 52-week high of €18.00 and above its 52-week low of €0.34.

Revenue Growth

Year-on-year quarterly revenue growth declined by 99.4%, now sitting on 84k for the twelve trailing months.

Moving Average

OXURION’s worth is way below its 50-day moving average of €0.88 and way under its 200-day moving average of €1.72.

Volatility

OXURION’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.76%, a negative 5.32%, and a positive 9.71%.

OXURION’s highest amplitude of average volatility was 5.17% (last week), 6.48% (last month), and 9.71% (last quarter).

More news about OXURION.

10. BENFICA (SLBEN.LS)

4.53% Price Change

Sport Lisboa e Benfica – Futebol, SAD operates a sports club in Portugal. The company was founded in 1904 and is headquartered in Lisbon, Portugal. Sport Lisboa e Benfica – Futebol, SAD operates as a subsidiary of Sport Lisboa e Benfica SGPS SA.

PSI ended the session with BENFICA jumping 4.53% to €3.46 on Monday while PSI rose 0.69% to €6,693.16.

Earnings Per Share

As for profitability, BENFICA has a trailing twelve months EPS of €-1.36.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.79%.

Yearly Top and Bottom Value

BENFICA’s stock is valued at €3.46 at 22:40 EST, way below its 52-week high of €4.12 and way above its 52-week low of €2.62.

Volatility

BENFICA’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.53%, a negative 0.04%, and a positive 2.64%.

BENFICA’s highest amplitude of average volatility was 1.53% (last week), 3.19% (last month), and 2.64% (last quarter).

Moving Average

BENFICA’s worth is higher than its 50-day moving average of €3.34 and way above its 200-day moving average of €3.05.

Revenue Growth

Year-on-year quarterly revenue growth grew by 14.7%, now sitting on 195.8M for the twelve trailing months.

More news about BENFICA.

Losers Today

1. LAVIDE HOLDING (LVIDE.AS)

-14.55% Price Change

Lavide Holding N.V. does not have significant operations. Previously, it was engaged in the provision of integrated information technology solutions for medium to large-sized companies and organizations. The company was formerly known as Qurius N.V. and changed its name to Lavide Holding N.V. in July 2013. Lavide Holding N.V. is based in Amsterdam, the Netherlands.

AEX-Index ended the session with LAVIDE HOLDING dropping 14.55% to €0.36 on Monday while AEX-Index jumped 0.11% to €912.77.

Earnings Per Share

As for profitability, LAVIDE HOLDING has a trailing twelve months EPS of €-0.02.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, LAVIDE HOLDING’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for LAVIDE HOLDING is 133251 which is 551.4% above its average volume of 20456.

Volatility

LAVIDE HOLDING’s last week, last month’s, and last quarter’s current intraday variation average was 5.57%, 4.13%, and 5.62%.

LAVIDE HOLDING’s highest amplitude of average volatility was 18.21% (last week), 8.74% (last month), and 5.62% (last quarter).

Moving Average

LAVIDE HOLDING’s worth is way above its 50-day moving average of €0.28 and way higher than its 200-day moving average of €0.28.

More news about LAVIDE HOLDING.

2. ATLANTIC SAPPHIRE (ASA.OL)

-13.34% Price Change

Atlantic Sapphire ASA, together with its subsidiaries, engages in the production and sale of land-based salmon in Denmark and the United States. The company was incorporated in 2010 and is headquartered in Vikebukt, Norway.

Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE sliding 13.34% to €0.23 on Monday while Oslo Børs Benchmark Index_GI fell 0.48% to €1,442.48.

Earnings Per Share

As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-3.57.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

More news about ATLANTIC SAPPHIRE.

3. SEQUANA MEDICAL (SEQUA.BR)

-8.85% Price Change

Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, Switzerland, and internationally. The company products pipeline comprises alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body and heart failure. Sequana Medical NV was founded in 2006 and is headquartered in Ghent, Belgium.

BEL 20 ended the session with SEQUANA MEDICAL sliding 8.85% to €0.70 on Monday while BEL 20 fell 0.62% to €4,264.18.

Earnings Per Share

As for profitability, SEQUANA MEDICAL has a trailing twelve months EPS of €-1.22.

Yearly Top and Bottom Value

SEQUANA MEDICAL’s stock is valued at €0.70 at 22:40 EST, way below its 52-week high of €4.85 and way higher than its 52-week low of €0.47.

Moving Average

SEQUANA MEDICAL’s value is way below its 50-day moving average of €0.96 and way under its 200-day moving average of €1.85.

Volatility

SEQUANA MEDICAL’s last week, last month’s, and last quarter’s current intraday variation average was a negative 8.79%, a negative 1.46%, and a positive 4.70%.

SEQUANA MEDICAL’s highest amplitude of average volatility was 20.63% (last week), 5.77% (last month), and 4.70% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth declined by 72.5%, now sitting on 433.5k for the twelve trailing months.

More news about SEQUANA MEDICAL.

4. HAVILA SHIPPING (HAVI.OL)

-5.95% Price Change

Havila Shipping ASA, together with its subsidiaries, engages in the shipping business. It manages and operates offshore service vessels primarily in Norway, the United Kingdom, Denmark, Belgium, the Netherlands, Iceland, Tunisia, the Marshall Islands, and the United States. The company operates a fleet of vessels, including anchor handling vessels, platform supply vessels, rescue recovery vessel, and subsea vessels. Its subsea vessels are used for under water construction work, as well as for support for under water operations; and rescue recovery vessels are used to offer security services, such as oil spill preparedness, fire protection, rescue operation, and recovery at oil installations. In addition, the company offers renewable energy services comprising of cable repair, trenching and ploughing, mooring and towing, and daughter craft operations, and transport of equipment and good services. The company was founded in 2003 and is headquartered in Fosnavåg, Norway. Havila Shipping ASA is a subsidiary of Havila Holding AS.

Oslo Børs Benchmark Index_GI ended the session with HAVILA SHIPPING sliding 5.95% to €3.40 on Monday while Oslo Børs Benchmark Index_GI slid 0.48% to €1,442.48.

Earnings Per Share

As for profitability, HAVILA SHIPPING has a trailing twelve months EPS of kr0.17.

PE Ratio

HAVILA SHIPPING has a trailing twelve months price to earnings ratio of 20. Meaning, the purchaser of the share is investing kr20 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.13%.

Moving Average

HAVILA SHIPPING’s worth is way under its 50-day moving average of kr4.40 and way under its 200-day moving average of kr5.28.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HAVILA SHIPPING’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth declined by 24.7%, now sitting on 614.35M for the twelve trailing months.

More news about HAVILA SHIPPING.

5. HYBRID SOFTWARE GR (HYSG.BR)

-5.79% Price Change

Hybrid Software Group PLC, together with its subsidiaries, develops software and hardware technology solutions for graphics and industrial inkjet printing in the United Kingdom, rest of Europe, North and South America, and Asia. The company offers Harlequin Core, a raster image processor (RIP) software that converts text and image data from various file formats, including PDF, TIFF, and JPEG files; ScreenPro, a software that converts tone image data into ready-to-print halftone in real-time; and Mako SDK, a software that creates, rasterizes, converts, analyses, and optimizes various page description languages, as well as allows print software developers to control over colour, fonts, text, images, vector content, and metadata. It also provides Harlequin Direct, a software that drives print data directly to the printer electronics instead of buffering them on mass storage devices; SmartDFE, a turnkey digital front end based on Harlequin Direct, CLOUDFLOW, and Meteor for digital printing of labels and packaging; Navigator Harlequin RIP and Workflow, a software that offers prepress environments to interpretation of PostScript, PDF, and EPS format files; Navigator DFE, a software that helps to prepare jobs, manage colour, and control digital output devices built with Memjet or any standard inkjet printhead; and Output Device Interfaces, a hardware and software solutions to connect RIPs to computer-to-plate devices, imagesetters, proofers, digital presses, high-speed copiers, and inkjet printers. The company was formerly known as Global Graphics PLC and changed its name to Hybrid Software Group PLC in October 2021. Hybrid Software Group PLC was founded in 1986 and is headquartered in Cambridge, the United Kingdom. Hybrid Software Group PLC is a subsidiary of Congra Software S.à R.L.

BEL 20 ended the session with HYBRID SOFTWARE GR dropping 5.79% to €3.58 on Monday, following the last session’s upward trend. BEL 20 slid 0.62% to €4,264.18, following the last session’s upward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, HYBRID SOFTWARE GR has a trailing twelve months EPS of €0.12.

PE Ratio

HYBRID SOFTWARE GR has a trailing twelve months price to earnings ratio of 29.83. Meaning, the purchaser of the share is investing €29.83 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.37%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HYBRID SOFTWARE GR’s stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

HYBRID SOFTWARE GR’s stock is valued at €3.58 at 22:40 EST, way below its 52-week high of €4.38 and way higher than its 52-week low of €2.56.

Volume

Today’s last reported volume for HYBRID SOFTWARE GR is 520 which is 50.61% below its average volume of 1053.

More news about HYBRID SOFTWARE GR.

6. TIETOEVRY (TIETO.OL)

-5.63% Price Change

TietoEVRY Oyj operates as a software and services company. It operates through five segments: Tietoevry Create, Tietoevry Banking, Tietoevry Care, Tietoevry Industry, and Tietoevry Tech Services. The Tietoevry Create segment provides digital agenda to create competitive products, as well as uses design, data, and cloud technologies for data-driven businesses. This segment also offers software and data engineering services. The Tietoevry Banking segment provides Banking-as-a-Service platform and software products for digital transformation and financial institutions. The Tietoevry Care segment offers modular and interoperable software, reinventing Nordic health, and social care services. The Tietoevry Industry segment offers software and data solutions to various industries, such as public sector, pulp and paper, and utilities. The Tietoevry Tech Services provides enterprise-wide transformation to customers' business processes, applications and infrastructure; and deep customer knowledge, global cloud & data competencies, automated operations, and multi-cloud platform services. The company was formerly known as Tieto Oyj and changed its name to TietoEVRY Oyj in December 2019. TietoEVRY Oyj was incorporated in 1968 and is headquartered in Espoo, Finland.

Oslo Børs Benchmark Index_GI ended the session with TIETOEVRY sliding 5.63% to €201.00 on Monday while Oslo Børs Benchmark Index_GI dropped 0.48% to €1,442.48.

Earnings Per Share

As for profitability, TIETOEVRY has a trailing twelve months EPS of kr16.23.

PE Ratio

TIETOEVRY has a trailing twelve months price to earnings ratio of 12.38. Meaning, the purchaser of the share is investing kr12.38 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.41%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 2.8%, now sitting on 2.86B for the twelve trailing months.

Yearly Top and Bottom Value

TIETOEVRY’s stock is valued at kr201.00 at 22:40 EST, way under its 52-week high of kr253.00 and higher than its 52-week low of kr200.20.

Moving Average

TIETOEVRY’s value is below its 50-day moving average of kr219.56 and way under its 200-day moving average of kr226.84.

More news about TIETOEVRY.

7. SCANA (SCANA.OL)

-5.56% Price Change

Scana ASA engages in the offshore, energy, and maritime businesses in Norway, rest of European countries, America, Asia, Africa, and Oceania. The company offers valve remote control systems and mooring solutions to vessels, rigs, and floating structures serving the shipping, aquaculture, oil and gas, and energy industries. It also engages in the design and integration of electrical power systems, electrical infrastructure, and energy storage systems and control systems. In addition, the company is involved in the planning and execution of insulation, scaffolding, and surface treatment services; and rig, capping, equipment support, make and break, IMR lifecycle, welding, and asset integrity management services to drilling industry, as well as offers riser applications to the oil and gas industry. Scana ASA was formerly known as Incus Investor ASA and changed its name to Scana ASA in May 2020. The company was founded in 1646 and is headquartered in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with SCANA falling 5.56% to €3.23 on Monday while Oslo Børs Benchmark Index_GI dropped 0.48% to €1,442.48.

Earnings Per Share

As for profitability, SCANA has a trailing twelve months EPS of kr0.23.

PE Ratio

SCANA has a trailing twelve months price to earnings ratio of 14.04. Meaning, the purchaser of the share is investing kr14.04 for every norwegian krone of annual earnings.

Sales Growth

SCANA’s sales growth is 5.7% for the ongoing quarter and 15.7% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SCANA’s stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

SCANA’s stock is valued at kr3.23 at 22:40 EST, below its 52-week high of kr3.50 and way above its 52-week low of kr1.89.

More news about SCANA.

8. QUESTERRE ENERGY (QEC.OL)

-5.44% Price Change

Questerre Energy Corporation, an energy technology and innovation company, acquires, explores, and develops non-conventional oil and gas projects in Canada. It produces tight oil, oil shale, shale oil, and shale gas. The company primarily holds 40,320 acres located in Kakwa, Alberta, including 25% working interest in 10,080 acres in Kakwa Central; 50% working interest in 4,480 acres in Kakwa North; 50% interest in 22,040 acres in Kakwa West; and 50% interest in 3,840 acres in Kakwa South. It also has 100% working interest in 11,316 acres located in Antler, Saskatchewan; and oil shale assets in Jordan. The company was formerly known as Westpro Equipment Ltd. and changed its name to Questerre Energy Corporation in December 2000. The company was incorporated in 1971 and is headquartered in Calgary, Canada.

Oslo Børs Benchmark Index_GI ended the session with QUESTERRE ENERGY falling 5.44% to €2.26 on Monday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI slid 0.48% to €1,442.48, following the last session’s upward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, QUESTERRE ENERGY has a trailing twelve months EPS of kr-0.53.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -16.01%.

Moving Average

QUESTERRE ENERGY’s value is way above its 50-day moving average of kr1.98 and way higher than its 200-day moving average of kr1.87.

More news about QUESTERRE ENERGY.

9. TREASURE (TRE.OL)

-4.41% Price Change

Treasure ASA, through its 11% interest in Hyundai Glovis Co. Ltd., provides transportation and logistics services in South Korea. The company was incorporated in 2016 and is based in Lysaker, Norway. Treasure ASA is a subsidiary of Wilh. Wilhelmsen Holding ASA.

Oslo Børs Benchmark Index_GI ended the session with TREASURE sliding 4.41% to €26.20 on Monday while Oslo Børs Benchmark Index_GI fell 0.48% to €1,442.48.

Earnings Per Share

As for profitability, TREASURE has a trailing twelve months EPS of kr4.55.

PE Ratio

TREASURE has a trailing twelve months price to earnings ratio of 5.76. Meaning, the purchaser of the share is investing kr5.76 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.4%.

Volume

Today’s last reported volume for TREASURE is 18249 which is 8.79% above its average volume of 16773.

Volatility

TREASURE’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.09%, a positive 0.28%, and a positive 2.09%.

TREASURE’s highest amplitude of average volatility was 1.20% (last week), 1.91% (last month), and 2.09% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, TREASURE’s stock is considered to be oversold (<=20).

Moving Average

TREASURE’s value is higher than its 50-day moving average of kr25.88 and way higher than its 200-day moving average of kr22.01.

More news about TREASURE.

10. EQUINOR (EQNR.OL)

-4.21% Price Change

Equinor ASA, an energy company, engages in the exploration, production, transportation, refining, and marketing of petroleum and other forms of energy in Norway and internationally. It operates through Exploration & Production Norway; Exploration & Production International; Exploration & Production USA; Marketing, Midstream & Processing; Renewables; and Other segments. The company also transports, processes, manufactures, markets, and trades in oil and gas commodities, such as crude and condensate products, gas liquids, natural gas, and liquefied natural gas; trades in power and emissions; operates refineries, terminals and processing, and power plants; and develops low carbon solutions for oil and gas. In addition, it develops carbon capture and storage projects; provides transportation solutions, including pipelines, shipping, trucking, and rail; and develops and explores for renewable energy, such as offshore wind, green hydrogen, and solar power. The company was formerly known as Statoil ASA and changed its name to Equinor ASA in May 2018. Equinor ASA was incorporated in 1972 and is headquartered in Stavanger, Norway.

Oslo Børs Benchmark Index_GI ended the session with EQUINOR sliding 4.21% to €275.15 on Monday while Oslo Børs Benchmark Index_GI fell 0.48% to €1,442.48.

Earnings Per Share

As for profitability, EQUINOR has a trailing twelve months EPS of kr34.79.

PE Ratio

EQUINOR has a trailing twelve months price to earnings ratio of 7.91. Meaning, the purchaser of the share is investing kr7.91 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 52.91%.

Volume

Today’s last reported volume for EQUINOR is 2900480 which is 14.99% above its average volume of 2522230.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EQUINOR’s stock is considered to be oversold (<=20).

More news about EQUINOR.

Stay up to date with our winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *